United States. Securities and Exchange Commission

United States. Securities and Exchange Commission

Coherus BioSciences Receives FDA Approval for UDENYCA ONBODYtm On-Body Injector Presentation

Coherus BioSciences, Inc. announced the U.S. Food and Drug Administration's approval of UDENYCA ONBODYtm, a pegfilgrastim biosimilar administered via an on-body injector (OBI) to reduce the incidence of infection as manifested by febrile neutropenia. The approval was supported by comprehensive analytical and clinical data, including pharmacokinetic and